{"schema_version":"secwatch.filing_event.v1","accession":"0001551152-23-000040","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.481615+00:00","generated_at":"2026-06-09T06:59:32.845917+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"AbbVie Q3 adj EPS $2.95 (down 19.4%); raises FY23 and FY24 guidance; dividend up 4.7%","bullets":["Q3 GAAP diluted EPS $1.00 (down 54.8% YoY); adjusted diluted EPS $2.95 (down 19.4%); net rev $13.93B (down 6.0%).","Immunology down 11.3% as Humira fell 36.2%; Skyrizi up 52.1% and Rinvoq up 59.8% drove growth in other segments.","Raises 2023 adj EPS guidance to $11.19-$11.23 from $10.86-$11.06; 2024 floor raised to $11.00 from $10.70.","Dividend increased 4.7% to $1.55/quarter; payable Feb 15, 2024 to holders of record Jan 16, 2024.","Records $2.1B pre-tax impairment on Imbruvica intangible due to IRA price negotiation; remaining carrying value $1.8B."],"urls":{"canonical":"https://secwatch.observer/filing/0001551152-23-000040","json":"https://secwatch.observer/filing/0001551152-23-000040.json","markdown":"https://secwatch.observer/filing/0001551152-23-000040.md","text":"https://secwatch.observer/filing/0001551152-23-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000155115223000040/0001551152-23-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000155115223000040/abbv-20231027.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:59:32.845917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}